Addex Therapeutics (ADXN) EPS (Basic) (2022 - 2025)
Historic EPS (Basic) for Addex Therapeutics (ADXN) over the last 3 years, with Q3 2025 value amounting to -$0.01.
- Addex Therapeutics' EPS (Basic) rose 4584.71% to -$0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 million, marking a year-over-year decrease of 8543.12%. This contributed to the annual value of $100.8 million for FY2024, which is 6466232719659.12% up from last year.
- According to the latest figures from Q3 2025, Addex Therapeutics' EPS (Basic) is -$0.01, which was up 4584.71% from -$0.02 recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' EPS (Basic) registered a high of -$0.01 during Q2 2024, and its lowest value of -$138.5 million during Q4 2024.
- For the 3-year period, Addex Therapeutics' EPS (Basic) averaged around -$12.8 million, with its median value being -$0.02 (2025).
- Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 10235620144495.63% in 2024, then surged by 4584.71% in 2025.
- Over the past 3 years, Addex Therapeutics' EPS (Basic) (Quarter) stood at -$0.14 in 2023, then plummeted by 102356201444.96% to -$138.5 million in 2024, then skyrocketed by 100.0% to -$0.01 in 2025.
- Its EPS (Basic) was -$0.01 in Q3 2025, compared to -$0.02 in Q2 2025 and -$1.6 million in Q1 2025.